drugset

drugset / Trial / NCT00479726

Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)

NCT00479726 ↗

Phase 4 Completed 8000 enrolled Eli Lilly and Company

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting

Timeline

Start: 2004-08
Primary completion: —
Completion: 2005-01

Publications

Wohlreich MM, Wiltse CG, Desaiah D, Ye W, Robinson RL, Kroenke K, Kornstein SG, Greist JH. Duloxetine in practice-based clinical settings: assessing effects on the emotional and physical symptoms of depression in an open-label, multicenter study. Prim Care Companion J Clin Psychiatry. 2007;9(4):271-9. doi: 10.4088/pcc.v09n0404.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Duloxetine	Small molecule	60 mg	—

Indications